BIOMAT Database Logo BIOMAT Database Logo

Extensively drug-resistant tuberculosis: early access to bedaquiline for a UK patient. 2014

Clare van Halsema, and Susan Humphreys, and Alec Bonington
North Manchester General Hospital, Manchester.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D005260 Female Females
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D054242 Emigrants and Immigrants People who leave their place of residence in one country and settle in a different country. Emigrants,Immigrants,Aliens,Foreigners,Alien,Emigrant,Foreigner,Immigrant,Immigrants and Emigrants
D054908 Extensively Drug-Resistant Tuberculosis Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC. Tuberculosis, Extensively Drug-Resistant,Extremely Drug-Resistant Tuberculosis,Tuberculosis, Extremely Drug-Resistant,XDR-TB,Drug-Resistant Tuberculoses, Extensively,Drug-Resistant Tuberculoses, Extremely,Drug-Resistant Tuberculosis, Extensively,Drug-Resistant Tuberculosis, Extremely,Extensively Drug Resistant Tuberculosis,Extensively Drug-Resistant Tuberculoses,Extremely Drug Resistant Tuberculosis,Extremely Drug-Resistant Tuberculoses,Tuberculoses, Extensively Drug-Resistant,Tuberculoses, Extremely Drug-Resistant,Tuberculosis, Extensively Drug Resistant,Tuberculosis, Extremely Drug Resistant

Related Publications

Clare van Halsema, and Susan Humphreys, and Alec Bonington
Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis.
July 2019, The European respiratory journal,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
[Extensively drug-resistant tuberculosis treated with bedaquiline].
April 2023, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
October 2017, Emerging infectious diseases,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis.
January 2020, Southern African journal of infectious diseases,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
February 2016, The European respiratory journal,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Extensively drug resistant tuberculosis in a HIV-infected patient in a UK hospital.
January 2013, International journal of STD & AIDS,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Clinical access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis.
March 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
January 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
June 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Clare van Halsema, and Susan Humphreys, and Alec Bonington
Extensively drug-resistant tuberculosis in the UK: 1995 to 2007.
June 2009, Thorax,
Copied contents to your clipboard!